{
    "id": "dbpedia_6044_1",
    "rank": 17,
    "data": {
        "url": "https://asia.nikkei.com/Business/Biotechnology/China-s-Sinopharm-doubles-output-capacity-for-2020-vaccine-launch",
        "read_more_link": "",
        "language": "en",
        "title": "China's Sinopharm doubles output capacity for 2020 vaccine launch",
        "top_image": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fcms-image-bucket-production-ap-northeast-1-a7d2.s3.ap-northeast-1.amazonaws.com%2Fimages%2F2%2F7%2F0%2F1%2F28061072-1-eng-GB%2FRTS3CIYD_2048x1152.jpg?width=1260&height=630&fit=cover&gravity=faces&source=nar-cms",
        "meta_img": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fcms-image-bucket-production-ap-northeast-1-a7d2.s3.ap-northeast-1.amazonaws.com%2Fimages%2F2%2F7%2F0%2F1%2F28061072-1-eng-GB%2FRTS3CIYD_2048x1152.jpg?width=1260&height=630&fit=cover&gravity=faces&source=nar-cms",
        "images": [
            "https://www.facebook.com/tr?id=1076130949081971&ev=PageView&noscript=1",
            "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fcms-image-bucket-production-ap-northeast-1-a7d2.s3.ap-northeast-1.amazonaws.com%2Fimages%2F2%2F7%2F0%2F1%2F28061072-1-eng-GB%2FRTS3CIYD_2048x1152.jpg?width=700&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms",
            "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fcms-image-bucket-production-ap-northeast-1-a7d2.s3.ap-northeast-1.amazonaws.com%2Fimages%2F1%2F2%2F1%2F7%2F27487121-3-eng-GB%2FCropped-1591289282RTX32OB6.JPG?width=693&height=390&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms",
            "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fcms-image-bucket-production-ap-northeast-1-a7d2.s3.ap-northeast-1.amazonaws.com%2Fimages%2F3%2F2%2F4%2F3%2F27923423-1-eng-GB%2FRTS2GU51+%281%29.JPG?width=240&height=137&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms",
            "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fcms-image-bucket-production-ap-northeast-1-a7d2.s3.ap-northeast-1.amazonaws.com%2Fimages%2F6%2F3%2F5%2F4%2F27894536-3-eng-GB%2FCropped-159306086020200625+36Kr+main.jpeg?width=240&height=137&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms",
            "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fcms-image-bucket-production-ap-northeast-1-a7d2.s3.ap-northeast-1.amazonaws.com%2Fimages%2F0%2F3%2F7%2F6%2F44906730-4-eng-GB%2FCropped-1679512927-11-26T144415Z_1386840796_RC22JD9NXRA0_RTRMADP_3_GSK-RESULTS.JPG?width=240&height=137&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms",
            "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fcms-image-bucket-production-ap-northeast-1-a7d2.s3.ap-northeast-1.amazonaws.com%2Fimages%2F7%2F8%2F1%2F9%2F40459187-5-eng-GB%2FCropped-1653059050photo_SXM2022052000009293.jpg?width=240&height=137&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms",
            "https://asia.nikkei.com/bundles/app/images/placeholder.jpg?ez",
            "https://asia.nikkei.com/bundles/app/images/app-modal.png?ez"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "China's",
            "Sinopharm",
            "doubles",
            "output",
            "capacity",
            "2020",
            "vaccine",
            "launch"
        ],
        "tags": null,
        "authors": [
            "Staff"
        ],
        "publish_date": "2020-07-03T17:19:30+00:00",
        "summary": "",
        "meta_description": "DALIAN, China -- Chinese drugmaker Sinopharm has completed construction of a plant in Wuhan for mass production of a coronavirus vaccine candidate now",
        "meta_lang": "en",
        "meta_favicon": "/apple-touch-icon-144x144.png?ez",
        "meta_site_name": "Nikkei Asia",
        "canonical_link": "https://asia.nikkei.com/Business/Biotechnology/China-s-Sinopharm-doubles-output-capacity-for-2020-vaccine-launch",
        "text": "DALIAN, China -- Chinese drugmaker Sinopharm has completed construction of a plant in Wuhan for mass production of a coronavirus vaccine candidate now under development, doubling its capacity to more than 200 million doses a year\n\nThe state-backed company, known formally as China National Pharmaceutical Group, will be able to make 100 million doses a year at the site. The investment amount has not been disclosed. After the groundbreaking in March, construction took place quickly with support from the local government."
    }
}